keyword
MENU ▼
Read by QxMD icon Read
search

Medical Genetics, Epigenetics, Cancer Genetics

keyword
https://read.qxmd.com/read/30675194/circulating-tumor-dna-detection-a-potential-tool-for-colorectal-cancer-management
#1
REVIEW
Huizi Li, Changwen Jing, Jianzhong Wu, Jie Ni, Huanhuan Sha, Xiaoyue Xu, Yuanyuan Du, Rui Lou, Shuchen Dong, Jifeng Feng
Colorectal cancer (CRC) is frequently diagnosed at an advanced stage of the disease, the pathogenesis of which is influenced by genetic and epigenetic events. Circulating tumor DNA (ctDNA) is extracellular DNA that is present in a number of bodily fluids, including blood, synovial fluid and cerebrospinal fluid. Compared with performing a tissue biopsy, ctDNA examination presents the advantages of minimal invasion and greater convenience. ctDNA is commonly used to identify actionable genomic alterations, monitor treatment responses, unravel therapeutic resistance and potentially detect disease progression prior to clinical and radiological confirmation...
February 2019: Oncology Letters
https://read.qxmd.com/read/30591931/epigenetic-mechanisms-as-a-new-approach-in-cancer-treatment-an-updated-review
#2
REVIEW
Masoumeh Fardi, Saeed Solali, Majid Farshdousti Hagh
Epigenetic, along with genetic mechanisms, is essential for natural evolution and maintenance of specific patterns of gene expression in mammalians. Global epigenetic variation is inherited somatically and unlike genetic variation, it is dynamic and reversible. They are somatically associated with known genetic variations. Recent studies indicate the broad role of epigenetic mechanisms in the initiation and development of cancers, that they are including DNA methylation, histone modifications, nucleosomes changes, non-coding RNAs...
December 2018: Genes & Diseases
https://read.qxmd.com/read/30582481/epigenetic-targets-and-their-inhibitors-in-cancer-therapy
#3
Le Zhao, Yong-Tao Duan, Jun-Lei Wang, Ping Lu, Zhi-Juan Zhang, Xiao-Ke Zheng, Wei-Sheng Feng
Epigenetics is defined as the stable and heritable alternations in gene expression without changing the DNA nucleotide sequence. The initiation and progression of cancer result from not only genetic mutation, but also aberrant epigenetic regulation, such as DNA methylation and histones acetylation. Although Genetic alternations cannot be reversed, epigenetic modification is a dynamic and reversible process. Over the past few decades, much progress has been made in the research of epigenetic medications and a variety of drugs have been developed targeting at epigenetic regulatory proteins, which are capable of restoring malignant cancer cells to the normal state...
December 23, 2018: Current Topics in Medicinal Chemistry
https://read.qxmd.com/read/30538792/plant-natural-modulators-in-breast-cancer-prevention-status-quo-and-future-perspectives-reinforced-by-predictive-preventive-and-personalized-medical-approach
#4
REVIEW
Sona Uramova, Peter Kubatka, Zuzana Dankova, Andrea Kapinova, Barbora Zolakova, Marek Samec, Pavol Zubor, Anthony Zulli, Vanda Valentova, Taeg Kyu Kwon, Peter Solar, Martin Kello, Karol Kajo, Dietrich Busselberg, Martin Pec, Jan Danko
In contrast to the genetic component in mammary carcinogenesis, epigenetic alterations are particularly important for the development of sporadic breast cancer (BC) comprising over 90% of all BC cases worldwide. Most of the DNA methylation processes are physiological and essential for human cellular and tissue homeostasis, playing an important role in a number of key mechanisms. However, if dysregulated, DNA methylation contributes to pathological processes such as cancer development and progression. A global hypomethylation of oncogenes and hypermethylation of tumor-suppressor genes are characteristic of most cancer types...
December 2018: EPMA Journal
https://read.qxmd.com/read/30523039/the-colocare-study-a-paradigm-of-transdisciplinary-science-in-colorectal-cancer-outcomes
#5
Cornelia M Ulrich, Biljana Gigic, Jürgen Böhm, Jennifer Ose, Richard Viskochil, Martin Schneider, Graham A Colditz, Jane C Figueiredo, William M Grady, Christopher I Li, David Shibata, Erin M Siegel, Adetunji T Toriola, Alexis Ulrich
BACKGROUND: Colorectal cancer is a leading cause of cancer death. Biomarkers to predict treatment outcomes are needed, as is evidence whether postdiagnosis diet and lifestyle can affect well-being and clinical outcomes. The international ColoCare Consortium aims to identify new biologic markers (e.g., metabolomic, transcriptomic, metagenomic, genetic, epigenetic, proteomic markers) that predict clinical outcomes, and to characterize associations between modifiable risk factors (e.g., diet, supplement use, physical activity) with short-term and long-term patient-reported and clinical outcomes among patients with colorectal cancer...
March 2019: Cancer Epidemiology, Biomarkers & Prevention
https://read.qxmd.com/read/30476540/dietary-phytochemicals-in-colorectal-cancer-prevention-and-treatment-a-focus-on-the-molecular-mechanisms-involved
#6
REVIEW
Sadia Afrin, Francesca Giampieri, Massimiliano Gasparrini, Tamara Y Forbes-Hernández, Danila Cianciosi, Patricia Reboredo-Rodriguez, Jiaojiao Zhang, Piera Pia Manna, Maria Daglia, Atanas Georgiev Atanasov, Maurizio Battino
Worldwide, colorectal cancer (CRC) remains a major cancer type and leading cause of death. Unfortunately, current medical treatments are not sufficient due to lack of effective therapy, adverse side effects, chemoresistance and disease recurrence. In recent decades, epidemiologic observations have highlighted the association between the ingestion of several phytochemical-enriched foods and nutrients and the lower risk of CRC. According to preclinical studies, dietary phytochemicals exert chemopreventive effects on CRC by regulating different markers and signaling pathways; additionally, the gut microbiota plays a role as vital effector in CRC onset and progression, therefore, any dietary alterations in it may affect CRC occurrence...
November 23, 2018: Biotechnology Advances
https://read.qxmd.com/read/30458176/could-the-endocrine-disruptor-bisphenol-a-be-implicated-in-the-pathogenesis-of-oral-and-oropharyngeal-cancer-metabolic-considerations-and-future-directions
#7
Rodopi Emfietzoglou, Nikolaos Spyrou, Christos S Mantzoros, Maria Dalamaga
Bisphenol-A (BPA), a prototype endocrine disrupting molecule, has been associated with many disease entities such as diabetes mellitus, obesity, polycystic ovarian disease, cardiovascular disease, reproductive and neurodevelopmental disorders. BPA has also been associated mainly with hormone sensitive cancers such as breast, prostate, endometrial, ovarian, testicular and thyroid cancers but also non-hormonal sensitive cancers such as cervical and lung cancers, osteosarcoma and meningioma. Recent research has investigated the sources of contamination which are responsible for higher BPA concentrations in the oral cavity and oropharyngeal space, representing the first site of BPA exposure after ingestion...
November 17, 2018: Metabolism: Clinical and Experimental
https://read.qxmd.com/read/30277670/diseases-of-the-oral-cavity-in-light-of-the-newest-epigenetic-research-possible-implications-for-stomatology
#8
REVIEW
Jadwiga Jośko-Ochojska, Katarzyna Rygiel, Lidia Postek-Stefańska
Epigenetics is the study of inheritable changes in gene expression without changes in the underlying deoxyribonucleic acid (DNA) sequence. The main mechanisms of epigenetic regulation include DNA methylation, modifications in histones, and micro-ribonucleic acids (miRNA). Recent research evidence has shown that environmental and lifestyle factors dynamically interact with the genome, influencing epigenetic changes, from development to the later stages of life. This happens across a spectrum, from physiological to pathological conditions, such as genetic defects, developmental disorders, infectious or inflammatory processes, cancers, mental disorders, and substance abuse...
October 2, 2018: Advances in Clinical and Experimental Medicine: Official Organ Wroclaw Medical University
https://read.qxmd.com/read/30086794/a-nexus-model-of-cellular-transition-in-cancer
#9
REVIEW
Mukesh Yadav, Payal Chatterjee, Simran Tolani, Jaya Kulkarni, Meenakshi Mulye, Namrata Chauhan, Aditi Sakhi, Sakshi Gorey
The exact cause of cancer is one of the most immutable medical questions of the century. Cancer as an evolutionary disease must have a purpose and understanding the purpose is more important than decoding the cause. The model of cancer proposed herein, provides a link between the cellular biochemistry and cellular genetics of cancer evolution. We thus call this model as the "Nexus model" of cancer. The Nexus model is an effort to identify the most apparent route to the disease. We have tried to utilize existing cancer literature to identify the most plausible causes of cellular transition in cancer, where the primary cancer-causing agents (physical, chemical or biological) act as inducing factors to produce cellular impeders...
August 7, 2018: Biological Research
https://read.qxmd.com/read/30003270/targeting-epigenetics-using-synthetic-lethality-in-precision-medicine
#10
REVIEW
Ee Sin Chen
Technological breakthroughs in genomics have had a significant impact on clinical therapy for human diseases, allowing us to use patient genetic differences to guide medical care. The "synthetic lethal approach" leverages on cancer-specific genetic rewiring to deliver a therapeutic regimen that preferentially targets malignant cells while sparing normal cells. The utility of this system is evident in several recent studies, particularly in poor prognosis cancers with loss-of-function mutations that become "treatable" when two otherwise discrete and unrelated genes are targeted simultaneously...
September 2018: Cellular and Molecular Life Sciences: CMLS
https://read.qxmd.com/read/29976178/study-protocol-of-the-raps-study-novel-risk-adapted-prevention-strategies-for-people-with-a-family-history-of-colorectal-cancer
#11
Kaja Tikk, Korbinian Weigl, Michael Hoffmeister, Svitlana Igel, Matthias Schwab, Jochen Hampe, Stefanie J Klug, Ulrich Mansmann, Frank Kolligs, Hermann Brenner
BACKGROUND: People aged 40-60 years with a family history (FH) of colorectal cancer (CRC) in 1st degree relatives (FDRs) have a 2- to 4-fold increased risk of CRC compared to the average risk population. Therefore, experts recommend starting CRC screening earlier for this high-risk group. However, information on prevalence of relevant colonoscopic findings in this group is sparse, and no risk adapted screening offers are implemented in the German health care system. For example, screening colonoscopy is uniformly offered from age 55 on, regardless of family history...
July 6, 2018: BMC Cancer
https://read.qxmd.com/read/29947826/how-does-the-social-environment-during-life-course-embody-in-and-influence-the-development-of-cancer
#12
Ming Chen, Huiyun Zhu, Yiqi Du, Geliang Yang
OBJECTIVES: This review assessed the complex longitudinal processes involved in cancer etiology during life course to understand how the social inequality may be embodied in and influence cancer risk. METHODS: A narrative literature review was performed with a keyword search conducted using PubMed, Scientific Electronic Library Online and Google. Three aspects of literatures were mainly included: social environmental mechanisms of cancer, life course of cancer development and social inequality of cancer risk...
September 2018: International Journal of Public Health
https://read.qxmd.com/read/29876001/stk3-is-a-therapeutic-target-for-a-subset-of-acute-myeloid-leukemias
#13
Aylin Camgoz, Maciej Paszkowski-Rogacz, Shankha Satpathy, Martin Wermke, Martin V Hamann, Malte von Bonin, Chunaram Choudhary, Stefan Knapp, Frank Buchholz
Acute myeloid leukemia (AML) is characterized by uncontrolled proliferation and accumulation of immature myeloblasts, which impair normal hematopoiesis. While this definition categorizes the disease into a distinctive group, the large number of different genetic and epigenetic alterations actually suggests that AML is not a single disease, but a plethora of malignancies. Still, most AML patients are not treated with targeted medication but rather by uniform approaches such as chemotherapy. The identification of novel treatment options likely requires the identification of cancer cell vulnerabilities that take into account the different genetic and epigenetic make-up of the individual tumors...
May 22, 2018: Oncotarget
https://read.qxmd.com/read/29807577/progress-in-low-dose-health-risk-research-novel-effects-and-new-concepts-in-low-dose-radiobiology
#14
REVIEW
Dietrich Averbeck, Sisko Salomaa, Simon Bouffler, Andrea Ottolenghi, Vere Smyth, Laure Sabatier
People are more often exposed to low as opposed to high doses of ionising radiation (IR). Knowledge on the health risks associated with exposures to ionising radiation above 100 mGy is quite well established, while lower dose risks are inferred from higher level exposure information (ICRP). The health risk assessments are mainly based on epidemiological data derived from the atomic bombing of Hiroshima and Nagasaki, medical exposure studies and follow-up studies after nuclear accidents. For the estimation of long-term stochastic radiation health effects (such as cancer) and radiation protection purposes, a linear non-threshold (LNT) model is applied...
April 2018: Mutation Research
https://read.qxmd.com/read/29799080/the-challenge-of-drug-resistance-in-cancer-treatment-a-current-overview
#15
Michail Nikolaou, Athanasia Pavlopoulou, Alexandros G Georgakilas, Efthymios Kyrodimos
It is generally accepted that recent advances in anticancer agents have contributed significantly to the improvement of both the disease-free survival and quality of life in cancer patients. However, in many instances, a favorable initial response to treatment changes afterwards, thereby leading to cancer relapse and recurrence. This phenomenon of acquired resistance to therapy, it is a major problem for totally efficient anticancer therapy. The failure to obtain an initial response reflects a form of intrinsic resistance...
April 2018: Clinical & Experimental Metastasis
https://read.qxmd.com/read/29707086/epigenetics-of-metabolic-syndrome-as-a-mood-disorder
#16
REVIEW
Sermin Kesebir
Mood disorders comprise major depressive disorder (MDD), bipolar disorder (BD) and the milder forms of these two disorders. Reccurring MDD is also known as unipolar disorder. The distinction between unipolar and bipolar disorders was first suggested in 1957 by Leonard and was made official after support by several studies in 1980. Indeed, in 150 AD, Aretaeus of Cappadocia wrote "It seems to me that melancholia is the beginning and a part of mania". Additionally, Kraepelin, who proposed the first medical disease model in psychiatry a century ago, considered recurrent unipolar depression cases under the category of bipolar disorder and conceptualized spectrum disorders...
June 2018: Journal of Clinical Medicine Research
https://read.qxmd.com/read/29605047/biological-origins-of-sexual-orientation-and-gender-identity-impact-on-health
#17
REVIEW
Katherine A O'Hanlan, Jennifer C Gordon, Mackenzie W Sullivan
Gynecologic Oncologists are sometimes consulted to care for patients who present with diverse gender identities or sexual orientations. Clinicians can create more helpful relationships with their patients if they understand the etiologies of these diverse expressions of sexual humanity. Multidisciplinary evidence reveals that a sexually dimorphic spectrum of somatic and neurologic anatomy, traits and abilities, including sexual orientation and gender identity, are conferred together during the first half of pregnancy due to genetics, epigenetics and the diversity of timing and function of sex chromosomes, sex-determining protein secretion, gonadal hormone secretion, receptor levels, adrenal function, maternally ingested dietary hormones, fetal health, and many other factors...
April 2018: Gynecologic Oncology
https://read.qxmd.com/read/29475968/mirna-processing-gene-methylation-and-cancer-risk
#18
Brian T Joyce, Yinan Zheng, Zhou Zhang, Lei Liu, Masha Kocherginsky, Robert Murphy, Chad J Achenbach, Jonah Musa, Firas Wehbe, Allan Just, Jincheng Shen, Pantel Vokonas, Joel Schwartz, Andrea A Baccarelli, Lifang Hou
Background: Dysregulation of miRNA and methylation levels are epigenetic hallmarks of cancer, potentially linked via miRNA-processing genes. Studies have found genetic alterations to miRNA-processing genes in cancer cells and human population studies. Our objective was to prospectively examine changes in DNA methylation of miRNA-processing genes and their associations with cancer risk. Methods: We examined cohort data from the Department of Veterans' Affairs Normative Aging Study. Participants were assessed every 3 to 5 years starting in 1999 through 2013 including questionnaires, medical record review, and blood collection...
May 2018: Cancer Epidemiology, Biomarkers & Prevention
https://read.qxmd.com/read/29438472/klinefelter-syndrome-integrating-genetics-neuropsychology-and-endocrinology
#19
Claus H Gravholt, Simon Chang, Mikkel Wallentin, Jens Fedder, Philip Moore, Anne Skakkebæk
Although first identified over 70 years ago, Klinefelter syndrome (KS) continues to pose substantial diagnostic challenges, as many patients are still misdiagnosed, or remain undiagnosed. In fact, as few as 25% of patients with KS are accurately diagnosed and most of these diagnoses are not made until adulthood. Classic characteristics of KS include small testes, infertility, hypergonadothropic hypogonadism, and cognitive impairment. However, the pathophysiology behind KS is not well understood, although genetic effects are also thought to play a role...
August 1, 2018: Endocrine Reviews
https://read.qxmd.com/read/29401301/single-molecule-real-time-smrt-sequencing-comes-of-age-applications-and-utilities-for-medical-diagnostics
#20
Simon Ardui, Adam Ameur, Joris R Vermeesch, Matthew S Hestand
Short read massive parallel sequencing has emerged as a standard diagnostic tool in the medical setting. However, short read technologies have inherent limitations such as GC bias, difficulties mapping to repetitive elements, trouble discriminating paralogous sequences, and difficulties in phasing alleles. Long read single molecule sequencers resolve these obstacles. Moreover, they offer higher consensus accuracies and can detect epigenetic modifications from native DNA. The first commercially available long read single molecule platform was the RS system based on PacBio's single molecule real-time (SMRT) sequencing technology, which has since evolved into their RSII and Sequel systems...
March 16, 2018: Nucleic Acids Research
keyword
keyword
159312
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"